These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35663925)

  • 1. Preferences for Multipurpose Technology and Non-oral Methods of Antiretroviral Therapy Among Women Living With HIV in Western Kenya: A Survey Study.
    Bernard C; Jakait B; Fadel WF; Mocello AR; Onono MA; Bukusi EA; Wools-Kaloustian KK; Cohen CR; Patel RC
    Front Glob Womens Health; 2022; 3():869623. PubMed ID: 35663925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancies among women living with HIV using contraceptives and antiretroviral therapy in western Kenya: a retrospective, cohort study.
    Patel RC; Amorim G; Jakait B; Shepherd BE; Mocello AR; Musick B; Bernard C; Onono M; Bukusi EA; Wools-Kaloustian K; Cohen CR; Yiannoutsos CT;
    BMC Med; 2021 Aug; 19(1):178. PubMed ID: 34384443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.
    Patel RC; Morroni C; Scarsi KK; Sripipatana T; Kiarie J; Cohen CR
    J Int AIDS Soc; 2017 May; 20(1):21396. PubMed ID: 28530033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda.
    Nieves CI; Kaida A; Seage GR; Kabakyenga J; Muyindike W; Boum Y; Mocello AR; Martin JN; Hunt PW; Haberer JE; Bangsberg DR; Matthews LT
    Contraception; 2015 Aug; 92(2):152-9. PubMed ID: 25983013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
    Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
    J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
    [No Abstract]   [Full Text] [Related]  

  • 6. Making the Case for Joint Decision-Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative Findings on MPT Attribute Preferences from the CUPID Study (MTN-045).
    Bhushan NL; Musara P; Hartmann M; Stoner MCD; Shah SR; Nabukeera J; Rukundo I; Mutero P; Lewis MA; Piper J; Shapley-Quinn MK; Etima J; Minnis AM
    J Int AIDS Soc; 2022 Oct; 25(10):e26024. PubMed ID: 36254362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraception use and HIV outcomes among women initiating dolutegravir-containing antiretroviral therapy in Kenya: a retrospective cohort study.
    Humphrey JM; Omodi V; Bernard C; Maina M; Thorne J; Mwangi A; Wools-Kaloustian K; Patel RC
    J Int AIDS Soc; 2022 Dec; 25(12):e26046. PubMed ID: 36567432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-Users' Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa.
    Weinrib R; Minnis A; Agot K; Ahmed K; Owino F; Manenzhe K; Cheng H; van der Straten A
    AIDS Behav; 2018 Jan; 22(1):133-145. PubMed ID: 29052018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive and abortion practices of young Ghanaian women aged 15-24: evidence from a nationally representative survey.
    Keogh SC; Otupiri E; Castillo PW; Li NW; Apenkwa J; Polis CB
    Reprod Health; 2021 Jul; 18(1):150. PubMed ID: 34275462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis.
    Milali MP; Resar D; Kaftan D; Campbell J; Olowu A; Edwards D; Platais I; Kim HY; Jenkins S; Bershteyn A
    Front Reprod Health; 2023; 5():1144217. PubMed ID: 37266447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women Want Choices: Opinions from the Share.Learn.Shape Global Internet Survey About Multipurpose Prevention Technology (MPT) Products in Development.
    Friedland BA; Plagianos M; Savel C; Kallianes V; Martinez C; Begg L; Guthrie KM; Venkatasetty D; Pickett J; Haddad LB
    AIDS Behav; 2023 Jul; 27(7):2190-2204. PubMed ID: 36881183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Condom, modern contraceptive, and dual method use are associated with HIV status and relationship concurrency in a context of high mobility: A cross-sectional study of women of reproductive age in rural Kenya and Uganda, 2016.
    Lee JK; Gutin SA; Getahun M; Okiring J; Neilands TB; Akullian A; Ssali S; Cohen CR; Maeri I; Eyul P; Kamya MR; Bukusi EA; Charlebois ED; Camlin CS
    Contraception; 2023 Jan; 117():13-21. PubMed ID: 36115610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy.
    Pyra M; Heffron R; Mugo NR; Nanda K; Thomas KK; Celum C; Kourtis AP; Were E; Rees H; Bukusi E; Baeten JM;
    AIDS; 2015 Nov; 29(17):2353-9. PubMed ID: 26544706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
    Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
    Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.
    Mataboge P; Mthimkhulu N; Kutywayo A; Martin CE; Mazibuko M; Kwatsha K; Makalela N; Briedenhann E; Butler V; Bothma R; Mullick S
    BMC Public Health; 2023 Oct; 23(1):2090. PubMed ID: 37880628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.
    Bhushan NL; Ridgeway K; Luecke EH; Palanee-Phillips T; Montgomery ET; Minnis AM
    Front Reprod Health; 2023; 5():1156864. PubMed ID: 37325244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.
    Minnis AM; Browne EN; Boeri M; Agot K; van der Straten A; Ahmed K; Weinrib R; Mansfield C
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):394-403. PubMed ID: 30633040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of the COVID-19 pandemic on access to HIV and reproductive health care among women living with HIV (WLHIV) in Western Kenya: A mixed methods analysis.
    Bernard C; Hassan SA; Humphrey J; Thorne J; Maina M; Jakait B; Brown E; Yongo N; Kerich C; Changwony S; Qian SRW; Scallon AJ; Komanapalli SA; Enane LA; Oyaro P; Abuogi LL; Wools-Kaloustian K; Patel RC
    Front Glob Womens Health; 2022; 3():943641. PubMed ID: 36578364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive use among sexually active women living with HIV in western Ethiopia.
    Feyissa TR; Harris ML; Forder PM; Loxton D
    PLoS One; 2020; 15(8):e0237212. PubMed ID: 32760140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.
    van der Straten A; Agot K; Ahmed K; Weinrib R; Browne EN; Manenzhe K; Owino F; Schwartz J; Minnis A;
    J Int AIDS Soc; 2018 Mar; 21(3):e25094. PubMed ID: 29600595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.